TMCnet News

Innovid Reports Q4 and Fiscal Year 2023 Financial Results
[February 27, 2024]

Innovid Reports Q4 and Fiscal Year 2023 Financial Results


  • Company exceeds both revenue and Adjusted EBITDA guidance for Q4 and full year 2023
  • Q4 revenue grew to $38.6 million, up 15% year-over-year
  • Q4 net loss improved to $1.7 million and Adjusted EBITDA* more than doubled to $8.3 million, representing a 21% Adjusted EBITDA margin*
  • Full-year 2023 operating cash flow of $12.4 million and free cash flow* of $1.4 million

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Innovid Corp. (NYSE: CTV) (the "Company"), an independent platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital, today announced financial results for the fourth fiscal quarter and full year ended December 31, 2023.

"We're very proud to close out a transformational year at Innovid and exit 2023 with solid business momentum. We exceeded our revenue and Adjusted EBITDA guidance, demonstrated sequential improvement each quarter, and generated positive free cash flow for the year," said Zvika Netter, Co-Founder and CEO. "We continue to sit in an excellent position as more CTV ad-supported platforms gain momentum and live sports rights shift to streaming. We remain dedicated to driving accelerated and profitable growth in our business and have a strong conviction in our massive market opportunity."

Fourth Quarter 2023 Financial Summary

  • Revenue increased to $38.6 million, reflecting year-over-year growth of 15%.
  • CTV revenue, from Ad Serving and Personalization, increased to $14.2 million, up 14% year-over-year.
  • Measurement contributed $8.6 million, up 14% year-over-year, representing 22% of revenue.
  • Net loss was $1.7 million, compared to a net loss of $3.4 million for the same period in 2022.
  • Adjusted EBITDA* more than doubled to $8.3 million, compared to $3.0 million for the same period in 2022, representing a 21% Adjusted EBITDA margin*.
  • Operating cash flow was $4.3 million, compared to a use of $1.5 million in the same period of 2022.
  • Free cash flow* was $2.2 million, an increase of $6.9 million, compared to a use of $4.7 million in the same period in 2022.
  • Cash and cash equivalents as of December 31, 2023 increased from the prior quarter by $1.9 million, to a total of $49.6 million.

Full Year 2023 Financial Summary

  • Revenue increased to $140 million, reflecting year-over-year as-reported growth of 10%.
  • CTV revenue, from Ad Serving and Personalization, increased to $53.2 million, up 9% year-over-year.
  • Measurement contributed $31.8 million, representing 23% of revenue.
  • Net loss was $31.9 million, compared to a net loss of $18.4 million in 2022.
  • Adjusted EBITDA* increased to $19.4 million, compared to $1.2 million in 2022, representing a 14% Adjusted EBITDA margin*.
  • Operating cash flow was $12.4 million, compared to a use of $11.6 million in 2022.
  • Free cash flow* of $1.4 million improved by $23.4 million, compared to a use of $22.0 million in 2022.

Recent Business Highlights

  • CTV accounted for 52% of all video impressions served in Q4 2023.
  • Significant customer wins and expansions in the fourth quarter included Nexstar, PetSmart, Philips, and Rain the Growth Agency.
  • At Disney's Global Tech and Data Showcase, Disney Advertising introduced a dashboard powered by Innovid technology and outcomes measurement for real-time creative optimization.

Financial Outlook

Innovid anticipates continued revenue growth and margin expansion in 2024 as reflected in the following financial guidance for Q1 and full year 2024:

  • Q1 2024 revenue in a range between $34 million and $36 million, reflecting growth between 11% and 18%.
  • Q1 2024 Adjusted EBITDA* in a range between $3.0 million and $4.0 million.
  • FY 2024 revenue in a range between $154 million and $162 million, reflecting growth of 10% to 16%.
  • FY 2024 Adjusted EBITDA* in a range between $22 million and $28 million.

*See Use of Non-GAAP Financial Information and Reconciliation of GAAP to Non-GAAP Financial Measures table.

Conference Call

The Company will host a conference call and webcast to discuss fourth quarter and full year 2023 financial results today at 8:30 a.m. Eastern Time. Hosting the call will be Zvika Netter, Co-founder and Chief Executive Officer and Anthony Callini, Chief Financial Officer. The conference call will be available via webcast at investors.innovid.com. To participate via telephone, please dial 877-407-3211 (toll free) or 201-389-0862, and click here for international dial-ins.

Following the call, a replay of the webcast will be available for 90 days on the Innovid Investor Relations website.

Non-GAAP Measures and Certain Operational Metrics

Innovid prepares audited consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP"). Innovid also discloses and discusses non-GAAP financial measures such as Adjusted EBITDA,  Adjusted EBITDA margin percent and Free Cash Flow.

We use Adjusted EBITDA, Adjusted EBITDA margin percent and Free Cash Flow as measures of operational efficiency to understand and evaluate our core business operations. We believe  that these non-GAAP financial measures are also useful to investors for period-to-period comparisons of our core business as well as comparisons to peers as similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate businesses in our industry. We believe these figures provide an understanding and evaluation of our trends when comparing our operating results, on a consistent basis, by excluding items that we do not believe are indicative of our core operating performance. However, these non-GAAP financial measures should not take the place of GAAP financial measures in evaluating our business.

These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under GAAP. Some of the limitations of these measures are:

  • They do not reflect changes in, or cash requirements for, our working capital needs.
  • Adjusted EBITDA does not reflect our capital expenditures or future requirements for capital expenditures or contractual commitments.
  • They do not reflect costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy.
  • They do not reflect one-time, non-recurring, bonus costs and third-party costs associated with the SPAC merger transaction and regulatory filings.
  • They do not reflect goodwill impairment.
  • They do not reflect severance costs.
  • They do not reflect income tax expense or the cash requirements to pay income taxes.
  • They do not reflect our interest expense or the cash requirements necessary to service interest or principal payments on our debt.
  • Although depreciation and amortization are non-cash charges related mainly to intangible assets and amortization of software development costs, certain assets being depreciated and amortized will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.

Adjusted EBITDA is defined as net loss attributable to Innovid, excluding (1) depreciation, amortization and long-lived assets impairment, (2) goodwill impairment, (3) stock-based compensation, (4) finance (income) expenses, net, (5) transaction related expenses, (6) acquisition related expenses, (7) retention bonus expenses, (8) legal claims, (9) severance cost, (9) other, and (10) taxes on income.

We calculate Adjusted EBITDA margin percent as Adjusted EBITDA divided by total revenue.

We define Free Cash Flow as net cash provided by operating activities less capital expenditures and the impact of foreign exchange on cash. We sometimes refer to net cash provided by operating activities, the GAAP financial measure most directly comparable to free cash flow, as "operating cash flow."

Other companies in our industry may calculate the above described non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure. You should compensate for these limitations by relying primarily on our US GAAP results and using the non-GAAP financial measures only supplementally.

Innovid has provided a reconciliation of Adjusted EBITDA and Adjusted EBITDA margin percent to net (loss) income, the most directly comparable GAAP measure, for historical periods in the appendix hereto. We also have provided a reconciliation of Free Cash Flow to net cash provided by operating activities. We are not able to provide a reconciliation of the projected Adjusted EBITDA to expected net (loss) income attributable to Innovid for the first quarter of 2024 or the full-year 2024, without unreasonable effort. This is due to the unknown effect, timing, and potential significance of the effects of taxes on income in multiple jurisdictions, finance (income)/expenses including valuations, among others. These items have in the past, and may in the future, significantly affect GAAP results in a particular period.

Forward Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1996. The Company's actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," "aim," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations regarding its future financial results, expected growth and future market opportunity. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results, including Innovid's ability to achieve and, if achieved, maintain profitability, decrease and/or changes in CTV audience viewership behavior, Innovid's failure to make the right investment decisions or to innovate and develop new solutions, inaccurate estimates or projections of future financial performance, Innovid's failure to manage growth effectively, the dependence of Innovid's revenues and business on the overall demand for advertising and a limited number of advertising agencies and advertisers, the actual or potential impacts of international conflicts and humanitarian crises on global markets, the rejection of digital advertising by consumers, future restrictions on Innovid's ability to collect, use and disclose data, market pressure resulting in a reduction of Innovid's revenues per impression, Innovid's failure to adequately scale its platform infrastructure, exposure to fines and liability if advertisers, publishers and data providers do not obtain necessary and requisite consents from consumers for Innovid to process their personal data, competition for employee talent, seasonal fluctuations in advertising activity, payment-related risks, interruptions or delays in services from third parties, errors, defects, or unintended performance problems in Innovid's platform, intense market competition, failure to comply with the terms of third party open source components, changes in tax laws or tax rulings, failure to maintain an effective system of internal controls over financial reporting, failure to comply with data privacy and data protection laws, infringement of third party intellectual property rights, difficulty in enforcing Innovid's own intellectual property rights, system failures, security breaches or cyberattacks, additional financing if required may not be available, the volatility of the price of Innovid's common stock and warrants, and other important factors discussed under the caption "Risk Factors" in Innovid's Annual Report on Form 10-K filed with the SEC on March 3, 2023, as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC's website at www.sec.gov and the Investors Relations section of Innovid's website at investors.innovid.com. You should carefully consider the risks and uncertainties described in the documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. The Company cautions not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

About Innovid

Innovid (NYSE: CTV) powers advertising delivery, personalization, and measurement across linear, connected TV (CTV) and digital for the world's largest brands. Through a global infrastructure that enables cross-platform ad serving, data-driven creative, and measurement, Innovid offers its clients always-on intelligence to optimize advertising investment across channels, platforms, screens, and devices. Innovid is an independent platform that leads the market in converged TV innovation, through proprietary technology and exclusive partnerships designed to reimagine TV advertising. Headquartered in New York City, Innovid serves a global client base through offices across the Americas, Europe, and Asia Pacific. To learn more, visit https://www.innovid.com/ or follow us on LinkedIn or X.

Contacts
Investor Contact
Brinlea Johnson
[email protected]

Media Contacts
Megan Garnett Coyle
[email protected]

Caroline Yodice
[email protected]





INNOVID, CORP. AND ITS SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except stock and per stock data)



December 31,


2023


2022

ASSETS




Cash and cash equivalents

$                   49,585


$                37,541

Short-term bank deposits

165


10,000

Trade receivables, net (allowance for credit losses of $321 and $65 at December 31, 2023, and December 31, 2022, respectively)

46,420


43,653

Prepaid expenses and other current assets

5,450


2,640

Total current assets

101,620


93,834

Long-term deposit

264


277

Long-term restricted deposits

412


430

Property and equipment, net

18,419


14,322

Goodwill

102,473


116,976

Operating lease right of use asset

1,435


2,910

Intangible assets, net

24,318


29,918

Other non-current assets

1,014


938

Total non-current assets

148,335


165,771

TOTAL ASSETS

$                 249,955


$              259,605





LIABILITIES AND STOCKHOLDERS' EQUITY




Trade payables

$                     2,810


$                  3,361

Employees and payroll accruals

14,060


10,165

Lease liabilities - current portion

1,200


2,186

Accrued expenses and other current liabilities

7,426


5,474

Total current liabilities

25,496


21,186

Long-term debt

20,000


20,000

Lease liabilities - non-current portion

634


1,636

Other non-current liabilities

7,528


6,554

Warrants liability

307


4,301

Total non-current liabilities

28,469


32,491

TOTAL LIABILITIES

53,965


53,677

COMMITMENTS AND CONTINGENT LIABILITIES




STOCKHOLDERS' EQUITY:




Common stock: $0.0001 par value - Authorized: 500,000,000 at December 31, 2023, and December 31, 2022; Issued and outstanding: 141,194,179 and 133,882,414 at December 31, 2023, and December 31, 2022, respectively

13


13

Additional paid-in capital

378,774


356,801

Accumulated deficit

(182,797)


(150,886)

TOTAL STOCKHOLDERS' EQUITY

195,990


205,928

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$                 249,955


$              259,605






 


INNOVID, CORP. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except stock and per stock data)




Three months ended December 31,


Year ended December 31,


2023


2022


2023


2022


(Unaudited)


(Unaudited)





Revenues

$           38,617


$           33,698


$         139,882


$         127,117

Cost of revenues (1)

8,521


8,376


33,805


30,187

Research and development (1)

6,399


6,842


26,878


31,118

Sales and marketing (1)

11,299


11,869


45,571


50,266

General and administrative (1)

10,759


8,688


39,086


39,144

Depreciation, amortization and long-lived assets impairment

4,188


2,662


12,996


6,143

Goodwill impairment



14,503


Operating loss

(2,549)


(4,739)


(32,957)


(29,741)

Finance (income) expenses, net

(407)


(2,693)


(3,420)


(13,348)

Loss before taxes

(2,142)


(2,046)


(29,537)


(16,393)

Taxes on income

(484)


1,383


2,374


2,017

Net loss

$            (1,658)


$            (3,429)


$          (31,911)


$          (18,410)

Net loss per share attributable to common stockholders








Basic and diluted

$              (0.01)


$              (0.03)


$              (0.23)


$              (0.14)

Weighted-average number of shares used in computing net loss per share attributable to common stockholders








Basic and diluted

140,770,251


133,687,918


138,577,786


130,756,484



(1)

Exclusive of depreciation, amortization, long-lived assets and goodwill impairment presented separately.

 


INNOVID, CORP. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except stock data)




Common stock

Additional paid-in
capital

Accumulated
deficit

Total stockholders'
equity


Number


Amount

Balance as of December 31, 2021

119,017,380


$                 12

$            293,719

$        (132,476)

$                    161,255

Common stock and equity awards issued for acquisition of TVS

11,549,465


1

47,151

47,152

Stock-based compensation


14,945

14,945

Stock options exercised and RSUs vested

3,315,569


*

986

986

Net loss


(18,410)

(18,410)

Balance as of December 31, 2022

133,882,414


$                 13

$            356,801

$        (150,886)

$                    205,928

Stock-based compensation


21,179

21,179

Stock options exercised and RSUs vested

7,311,765


*

794

794

Net loss


(31,911)

(31,911)

Balance as of December 31, 2023

141,194,179


$                 13

$            378,774

$        (182,797)

$                    195,990


*Represents an amount less than $1.

 


INNOVID, CORP. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, except stock and per stock data)




Year Ended December 31


2023


2022

Cash flows from operating activities:




Net loss

$             (31,911)


$             (18,410)

Adjustments to reconcile net loss to net cash used in operating activities:




Depreciation, amortization and long-lived assets impairment

12,996


6,143

Goodwill impairment

14,503


Stock-based compensation

20,000


13,781

Change in fair value of warrants

(3,994)


(14,671)

Loss on foreign exchange, net

729


Changes in operating assets and liabilities




Trade receivables, net

(2,767)


(4,045)

Prepaid expenses and other assets

(2,872)


755

Operating lease right of use assets

1,764


1,831

Trade payables

(551)


(622)

Employees and payroll accruals

3,895


1,710

Operating lease liabilities

(2,277)


(2,335)

Accrued expenses and other liabilities

2,925


4,302

Net cash provided by / (used in) operating activities

12,440


(11,561)

Cash flows from investing activities:




Acquisition of business, net of cash acquired


(99,097)

Internal use software capitalization

(9,630)


(9,961)

Purchase of property and equipment

(684)


(488)

Investment in short-term bank deposits

(165)


(10,000)

Withdrawal of  short-term bank deposits

10,000


Other deposits


120

Net cash used in investing activities

(479)


(119,426)

Cash flows from financing activities:




Proceeds from loans

35,000


14,000

Loan repayment

(35,000)


Payment of SPAC merger transaction costs


(3,185)

Proceeds from exercise of options

794


985

Net cash provided by financing activities

794


11,800

Effect of exchange rates on cash, cash equivalent and restricted cash

(729)


Increase (decrease) in cash, cash equivalents, and restricted cash

12,026


(119,187)

Cash, cash equivalents, and restricted cash, beginning of the period

37,971


157,158

Cash, cash equivalents, and restricted cash, end of the period

$               49,997


$               37,971

Supplemental disclosures:




Income taxes paid, net of tax refunds

$                1,508


$                   785

Interest paid

$                1,451


$                   675

Non-cash transactions:




Business combination consideration paid in stock

$                     —


$               47,152

Reconciliation of cash, cash equivalents, and restricted cash




Cash and cash equivalents

49,585


37,541

Long-term restricted deposits

412


430

Total cash, cash equivalents, and restricted cash

$               49,997


$               37,971


Key Metrics and Non-GAAP Financial Measures

In addition to our results determined in accordance with US GAAP, we believe that certain non-GAAP financial measures, including Adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA"), Adjusted EBITDA margin percent and Free Cash Flow are useful in evaluating our business. The following table presents a reconciliation from net loss, which is the most directly comparable GAAP financial measure to Adjusted EBITDA and Adjusted EBITDA margin percent, non-GAAP financial measures as used by management.

Adjusted EBITDA and Adjusted EBITDA Margin Percent



Three months ended
December 31,


Year ended December 31,

(in thousands)

2023


2022


2023


2022

Net loss

$   (1,658)


$ (3,429)


$ (31,911)


$  (18,410)

Net loss margin percent

(4.0) %


(10.0) %


(22.8) %


(14.5) %

Depreciation, amortization and long-lived assets impairment

4,188


2,662


12,996


6,143

Goodwill impairment



14,503


Stock-based compensation

4,437


3,826


20,000


13,878

Finance income, net (a)

(407)


(2,693)


(3,420)


(13,348)

Transaction related expenses (b)




393

Acquisition related expenses (c)




4,971

Retention bonus expenses (d)

98


862


662


3,152

Legal claims

580


407


1,656


1,506

Severance cost

1,277


9


2,123


755

Other

244



436


168

Taxes on income

(484)


1,383


2,374


2,017

Adjusted EBITDA

$     8,275


$  3,027


$  19,419


$    1,225

Adjusted EBITDA margin percent

21.4 %


9.0 %


13.9 %


1.0 %



(a)

Finance income, net consists mostly of remeasurement related to revaluation of our warrants, remeasurement of our foreign subsidiary's monetary assets, liabilities and operating results, and our interest income and expense.

(b)

Transaction related expenses consist of costs related to the SPAC merger transaction.

(c)

Acquisition related expenses consists of professional fees associated with the acquisition of TVS.

(d)

Retention bonus expenses consists of retention bonuses for TVS employees.



 

Free Cash Flow


We define Free Cash Flow as net cash provided by operating activities less capital expenditures and the impact of foreign exchange on cash.



Three months ended December 31,


Year ended December 31,


2023


2022


2023


2022

Net cash provided by operating activities

$        4,274


$     (1,472)


$     12,440


$   (11,561)

Loss on foreign exchange, net

*)


*)


(729)


*)

Capital expenditures

(2,124)


(3,192)


(10,314)


(10,449)

Free Cash Flow

$        2,150


$     (4,664)


$       1,397


$   (22,010)


*) foreign exchange impact on cash was immaterial.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovid-reports-q4-and-fiscal-year-2023-financial-results-302072230.html

SOURCE Innovid LLC


[ Back To TMCnet.com's Homepage ]